Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
about
The national review of asthma deaths: what did we learn and what needs to change?Asthma-related deathsManagement of acute asthma in adults in the emergency department: nonventilatory managementWhat is new with the beta2-agonists: issues in the management of asthma.Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trialThe use of electronic alerts in primary care computer systems to identify the over-prescription of short-acting beta2-agonists in people with asthma: a protocol for a systematic review.Underutilization of controller and rescue medications among older adults with asthma requiring hospital care.Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.Declining incidence of episodes of asthma: a study of trends in new episodes presenting to general practitioners in the period 1989-98.Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysisThe Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and childrenThe Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbationsShort-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study.Risk factors, management and outcomes of patients admitted with near fatal asthma to a tertiary care hospital in Riyadh.An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.Patterns of prescription of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort.Risk of emergency care, hospitalization, and ICU stays for acute asthma among recipients of salmeterol.Prognostic nomogram for inpatients with asthma exacerbation.Asthma management. The case for aiming at control rather than merely relief.Severe or life-threatening asthma exacerbation: patient heterogeneity identified by cluster analysis.Long-acting inhaled beta agonists.Asthma attacks: how can we reduce the risks?Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma.The use of electronic alerts in primary care computer systems to identify the excessive prescription of short-acting beta2-agonists for people with asthma: a systematic review.Insights into frequent asthma exacerbations from a primary care perspective and the implications of UK National Review of Asthma Deaths recommendations
P2860
Q26797462-31C3E647-5060-46C4-A066-D7C65BD280E8Q28073233-894F2AB8-B844-4E64-94B6-2AD209CDFE64Q28393362-EF49F072-0A4F-4512-96BC-3EDF613726D5Q33213762-47924E12-0C56-4551-8A15-DFA49074967FQ33698626-4BF7EB61-60DF-46C8-B811-73BF1646AFD6Q33698672-28A20FCC-61A1-4A0E-80F9-BE0B00966820Q33944042-0D926822-6E93-47A6-BB22-E107E5076A08Q35532670-0177DCCA-04B0-4056-9267-6485EFDDBF1DQ35533946-6E125EF4-043B-41EC-8A2B-E72590B7B242Q35696088-ED1B519E-041A-4B0D-BF3F-309F63FA9E09Q35939347-0FAD767D-F15D-40C8-813A-02CBE2DEC013Q36422663-62CB7B7E-E9FE-41EE-8C9B-76EFCF7C676BQ36566081-1AC88508-A45F-4EC6-84EF-46325767195BQ37107385-7185923E-D6E2-459C-A2CB-71781AD8228DQ37184413-F79828D0-7699-49E6-8FC4-5878098282FBQ37551074-8FEA70B9-2EA6-401C-88ED-CE4E534218CDQ37735203-054E26BC-C210-4A1D-B7F2-F271FBE39148Q38174445-1C5CC459-CFE7-4953-B523-A5111C7B36A7Q38502052-8D71DB1A-8F35-4DEA-9BF8-C99EF21DDC51Q38640360-1815CEAF-BA3B-4187-BD8C-9EF38FC6A3CEQ39449843-D6D6DDC8-3A62-42AA-83D5-4E8DB7203CFEQ39866659-A528C6E5-E94B-4049-A7B9-02473D85673EQ40433878-361CEF13-F171-468E-98C1-F4741AB4474EQ42432096-7A8F6EDA-B7B3-4989-89E6-CCC681361AEBQ50883385-1CB03094-A67E-4474-ACF1-E176E8599CAFQ53280153-B0947B77-8412-4B4F-B3A4-DAAD0722243EQ58719618-DF743BD4-510A-434A-8D3C-BDE747A1BF36
P2860
Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
@ast
Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
@en
Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
@nl
type
label
Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
@ast
Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
@en
Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
@nl
prefLabel
Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
@ast
Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
@en
Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
@nl
P2093
P1476
Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma.
@en
P2093
P304
P356
10.1183/09031936.94.07091602
P577
1994-09-01T00:00:00Z